Non-eosinophilic Asthma: Importance and Possible Mechanisms
Overview
Authors
Affiliations
There is increasing evidence that inflammatory mechanisms other than eosinophilic inflammation may be involved in producing the final common pathway of enhanced bronchial reactivity and reversible airflow obstruction that characterises asthma. A review of the literature has shown that, at most, only 50% of asthma cases are attributable to eosinophilic airway inflammation. It is hypothesised that a major proportion of asthma is based on neutrophilic airway inflammation, possibly triggered by environmental exposure to bacterial endotoxin, particulate air pollution, and ozone, as well as viral infections. If there are indeed two (or more) subtypes of asthma, and if non-eosinophilic (neutrophil mediated) asthma is relatively common, this would have major consequences for the treatment and prevention of asthma since most treatment and prevention strategies are now almost entirely focused on allergic/eosinophilic asthma and allergen avoidance measures, respectively. It is therefore important to study the aetiology of asthma further, including the underlying inflammatory profiles.
Depicting "arms race" of Rhipicephalus microplus and its host on a single frame platform.
De A, Ponraj P, Bhattacharya D Parasitol Res. 2025; 124(2):18.
PMID: 39903310 PMC: 11794405. DOI: 10.1007/s00436-025-08459-3.
Group 3 Innate Lymphoid Cells: A Potential Therapeutic Target for Steroid Resistant Asthma.
Berkinbayeva M, Gu W, Chen Z, Gao P Clin Rev Allergy Immunol. 2025; 68(1):1.
PMID: 39751959 PMC: 11698894. DOI: 10.1007/s12016-024-09012-3.
Han S, Kim B, Hyeon D, Jeong D, Ryu J, Nam J Nat Commun. 2024; 15(1):8628.
PMID: 39366998 PMC: 11452667. DOI: 10.1038/s41467-024-53038-2.
Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthma.
Scadding G, Gray C, Conti D, McDonald M, Backer V, Scadding G Front Allergy. 2024; 5:1404735.
PMID: 38812719 PMC: 11133565. DOI: 10.3389/falgy.2024.1404735.
Anand A, Castiglia E, Zamora M Curr Environ Health Rep. 2024; 11(2):210-224.
PMID: 38386269 PMC: 11180488. DOI: 10.1007/s40572-024-00430-1.